Take a look at upcoming IPC symposia and events.

Lilly Announces a New, Citrate-Free Formulation of Taltz® (ixekizumab)
Eli Lilly announced a new formula for Taltz® that contains the same active ingredient as the original formulation, but patients experience significantly less pain at the injection site.